Aerospace Employee Wage-Fixing Antitrust
Initial Case Filing
Hagens Berman filed a nationwide class-action lawsuit regarding wage-fixing and no-hire practices in the aerospace industry affecting aerospace engineers and their wages. The law firm is specifically scrutinizing the hiring and compensation practices of five of the nation's largest aerospace engine design, manufacture and service companies in the U.S. for what we believe has been a years-long wage-fixing, no-hire agreement, causing employees to receive far less for their work than they are legally owed. View case page »

Amazon.com Antitrust
Initial Case Filing
An independent investigation revealed that Amazon.com has violated federal antitrust price-fixing laws, causing its customers to pay artificially increased prices for products purchased via Amazon. Consumers have now filed a class-action lawsuit against Amazon for driving up prices on its website. View case page »

Amazon Bookseller Antitrust
Initial Case Filing
Retail bookstore owners filed a class-action lawsuit claiming that Amazon.com colluded with the Big Five nation’s largest publishers, Hachette Book Group, HarperCollins Publishers, Macmillan Publishers, Penguin Group Inc. and Simon & Schuster Inc., to illegally fix prices of trade books. The lawsuit states anticompetitive provisions fix the wholesale price of books and prevent Amazon’s competitors from competing on price or product availability. View case page »

Amazon E-Books
Initial Case Filing
Nearly a decade after Hagens Berman successfully sued Apple for colluding with the Big Five publishers to fix prices of e-books at an inflated level, the firm files suit against onetime upstart Amazon for doing the exact same thing. According to the lawsuit, Amazon and the Big Five entered into price-fixing agreements in 2015, which allowed the Big Five publishers to increase their e-book prices by up to 30%, while protecting Amazon from price competition from other e-book retailers. View case page »

Amazon Price Gouging
Initial Case Filing
The firm’s class-action lawsuit accusing Amazon of price-gouging during the COVID-19 pandemic has now been expanded to include a proposed class of all Amazon shoppers nationwide who purchased affected products. View case page »

Amitiza Antitrust
Initial Case Filing
Hagens Berman filed a class-action complaint on behalf of direct purchasers alleging brand and generic manufacturers of the prescription drug Amitiza entered into a pay-for-delay deal to delay sales of generic Amitiza. According to the suit, the agreement the companies made was worth “at least $29 million and as much as $280 million.”

Association of Zoos & Aquariums
Initial Case Filing
The Association of Zoos & Aquariums is the target of a new lawsuit claiming the association practiced discrimination and unlawful retaliation following an alleged sexual assault by the executive director of the Henry Vilas Zoo in Madison, Wisconsin. The suit was filed in King County Superior Court. View case page »

Danimer Scientific, Inc. (NASDAQ: DNMR)
Initial Case Filing
This securities class action on behalf of investors who purchased securities of Danimer Scientific Inc. from October 5, 2020 through May 4, 2021 seeks to recover damages caused by violations of the Securities Exchange Act of 1934 by Danimer and certain of its senior officers. View case page »

Dodge RAM CP4 Fuel Pump Defect
Initial Case Filing
Hagens Berman filed a class-action lawsuit against Fiat Chrysler and Cummins on behalf of 600,000 owners and lessors of 2018 – 2020 Dodge RAM Heavy Duty Cummins-equipped diesel trucks containing a defective CP4 fuel pump that causes sudden engine failure. 

Hyzon Motors Inc. (NASDAQ: HYZN)
Initial Case Filing
In this investor fraud class action, the litigation alleges that Hyzon misrepresented the nature of its “customer” contracts and severely embellished its “deals” and “partnerships” with customers. The lawsuit alleges that it could not deliver its announced vehicles in 2021, on its stated timeline. The truth emerged on Sept. 28, 2021, when analyst Blue Orca published a scathing report likening the company to a Chinese Lordstown Motors. View case page »

Invisalign
Initial Case Filing
The firm filed a class-action lawsuit in California federal court against Align Technology, the maker of popular teeth straightening technology Invisalign, after an investigation revealed that for years the company has held a tight monopoly on the market, allowing the company to overcharge consumers. View case page »

Lantus Insulin Antitrust
Amended Complaint
In this class-action lawsuit pertaining to the price of insulin, the District of Massachusetts permitted Lantus purchasers to amend their complaint to add a class representative (Meijer) and to add the Sanofi entity that sold Lantus in Puerto Rico as a defendant. View case page »

Oregon State University College Tuition Payback
Initial Case Filing
Students from Oregon State University filed a class-action lawsuit against the school demanding repayment for tuition, room and board and other fees amid the COVID-19-related campus closures and transition to online-only education. View case page »

Philips Recalled CPAP, BiPAP & Ventilator Injuries
Initial Case Filing
According to the lawsuit filed in 2021, Philips knew about substantial and material risks of using its CPAP, BIPAP and other assisted breathing machines long before it issued a recall. Patients, including the individual who brought this lawsuit, who used the recalled breathing machines have complained about “black particles” in their machines for several years. View case page »

RenovaCare, Inc. (Other OTC: RCAR)
Initial Case Filing
This case arises from an alleged fraudulent promotional scheme orchestrated by RenovaCare’s controlling shareholder and chairman, Harmel Rayat, designed to artificially inflate company’s stock price. View case page »

SOS Limited (NYSE: SOS)
Initial Case Filing
The 2021 complaint centers on SOS’s purported recent entry into the bitcoin mining business. On Jan. 21, 2021, SOS claimed to have purchased over 15,000 mining rigs from HY International Group New York for $20 million. One month later, it claimed that 5,000 mining rigs had already gone live. The complaint alleges that, in truth, SOS is a fraudulent stock promotion scheme that has concealed related party transactions, and has misrepresented the type and/or existence of bitcoin mining rigs SOS claimed to have purchased earlier this year. View case page »

Takeda Constipation Drug
Initial Case Filing
Hagens Berman hit Takeda Pharmaceutical Co. Ltd. with a proposed class action on behalf of a drug company in Massachusetts federal court who claims the pharmaceutical giant paid a competitor to keep a generic anti-constipation drug off the market for six years to preserve Takeda's monopoly. 

Takeda IBS Antitrust
Initial Case Filing
Hagens Berman filed a lawsuit against Takeda Pharmaceutical alleging that it broke antitrust law when it cut a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation drug Amitiza off the market for more than six years, according to a proposed class action in Massachusetts federal court.

Utah System of Higher Education COVID-19 Tuition
Initial Case Filing
Hagens Berman filed a class-action lawsuit on behalf of students against Utah’s state college system, the Utah System of Higher Education, demanding repayment for tuition and other mandatory fees citing the university’s COVID-19 campus closure and transition to online learning.

University of Oregon Tuition Payback
Initial Case Filing
Students from the University of Oregon filed a class-action lawsuit against the school demanding repayment for tuition, room and board and other fees amid the COVID-19-related campus closures and transition to online-only education. The University of Oregon sent students home, closed campus facilities and transitioned to online instruction in order to maintain social distancing and flatten the curve. In spite of this unprecedented disruption in collegiate life, the University of Oregon continued charging tuition – $4,986 to $9,745 for residents and $8,937 to $13,487 for nonresidents. View case page »

Vascepa Antitrust
Initial Case Filing
Hagens Berman filed a class-action complaint on behalf of end payors alleging the manufacturer of the brand drug Vascepa schemed to delay generic competition for the drug. The class accuses the drug’s maker of wrapping up all supply of the active pharmaceutical ingredient necessary to make the drugs in order to stifle competition. View case page »